...
首页> 外文期刊>Asian Journal of Pharmaceutical Sciences >Blends of hydrophobic and swelling agents in the swelling layer in the preparation of delayed-release pellets of a hydrophilic drug with low MW: Physicochemical characterizations and in-vivo evaluations
【24h】

Blends of hydrophobic and swelling agents in the swelling layer in the preparation of delayed-release pellets of a hydrophilic drug with low MW: Physicochemical characterizations and in-vivo evaluations

机译:制备低分子量亲水药物的延迟释放小丸时,在溶胀层中掺入疏水剂和溶胀剂的混合物:理化特性和体内评估

获取原文
           

摘要

Abstract In this study, a hydrophobic material, ethylcellulose, which was used as its aqueous suspension Surelease?, was combined with a swelling agent as the swelling layer to prepare delayed-release pellets for Danshensu, which is a hydrophilic drug with low MW. A rupturable, delayed-release pellet consists of a drug core, a swelling layer containing a swelling agent (cross-linked sodium carboxymethyl cellulose) with a hydrophobic agent (Surelease?), and a controlled layer composed by an insoluble, water-permeable polymeric coating (aqueous ethylcellulose dispersions) was developed in a fluidised bed. Results showed that blending Surelease? into the swelling layer could effectively extend the release of Danshensu from the pellets, which may be attributed to the slowed swelling rate by reduction of water penetration and improvement of mechanical integrity of the swelling layer. Drug in the delayed pellets showed sustained release in beagle dogs after oral administration with comparable in-vivo exposure to the uncoated drug pellets. In conclusion, blends of hydrophobic and swelling agents in the swelling layer in double-membrane pellets could achieve a delayed drug-release profile in?vitro, as well as delayed and sustained absorption in?vivo for highly soluble, low-MW drug. The present study highlighted the potential use of a delayed-release system for other hydrophilic, low-MW drugs to meet the formulation requirements for chronopharmacological diseases.
机译:摘要在本研究中,将疏水性物质乙基纤维素用作其水悬浮液Surelease ?,并与溶胀剂结合作为溶胀层,以制备丹参素的缓释微丸,后者是一种低分子量的亲水性药物。可破裂的,延迟释放的药丸由药芯,含有溶胀剂(交联的羧甲基纤维素钠)和疏水剂(Surelease?)的溶胀层以及由不溶性,透水性聚合物组成的控制层组成。在流化床中显影涂层(乙基纤维素水分散体)。结果表明,混配了Surelease?进入溶胀层可以有效地延长丹参素从丸粒中的释放,这可能归因于水渗透率的降低和溶胀层机械完整性的改善,溶胀速率降低。口服后,延迟药丸中的药物在比格犬中显示出持续释放,体内暴露于未包衣的药丸中。总之,在双膜药丸的溶胀层中,疏水剂和溶胀剂的混合物可以在体外获得延迟的药物释放曲线,并在体内延迟和持续吸收高溶解性,低分子量药物。本研究强调了将延迟释放系统用于其他亲水性,低分子量药物的潜力,以满足慢性药理学疾病的制剂要求。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号